Page last updated: 2024-10-19

niacinamide and Fever

niacinamide has been researched along with Fever in 8 studies

nicotinamide : A pyridinecarboxamide that is pyridine in which the hydrogen at position 3 is replaced by a carboxamide group.

Fever: An abnormal elevation of body temperature, usually as a result of a pathologic process.

Research Excerpts

ExcerptRelevanceReference
"Sorafenib is the standard first-line therapy for hepatocellular carcinoma (HCC) and probably ectopic hepatocellular carcinoma (EHCC) as well."7.83A case report: delayed high fever and maculopapules during Sorafenib treatment of ectopic hepatocellular carcinoma. ( Chen, X; Cui, T; Diao, X; Huang, S; Sun, J, 2016)
"The aim of this study was to investigate the relationship between fever within 2 weeks after the start of sorafenib therapy and treatment efficacy in patients with advanced hepatocellular carcinoma (HCC)."7.83Fever within 2 Weeks of Sorafenib Therapy Predicts Favorable Treatment Efficacy in Patients with Advanced Hepatocellular Carcinoma. ( Goto, H; Hayashi, K; Hirooka, Y; Honda, T; Ishigami, M; Ishikawa, T; Ishizu, Y; Kuzuya, T; Nakano, I, 2016)
"To evaluate the safety and efficacy of combined therapy with transarterial chemoembolization (TACE) and sorafenib for hepatocellular carcinoma (HCC) with portal venous tumour thrombus (PVTT)."7.80Safety and efficacy of transarterial chemoembolization plus sorafenib for hepatocellular carcinoma with portal venous tumour thrombus. ( Li, W; Li, XS; Pan, T; Wang, JP; Wu, PH; Xie, QK; Zhao, M, 2014)
"Sorafenib is the standard first-line therapy for hepatocellular carcinoma (HCC) and probably ectopic hepatocellular carcinoma (EHCC) as well."3.83A case report: delayed high fever and maculopapules during Sorafenib treatment of ectopic hepatocellular carcinoma. ( Chen, X; Cui, T; Diao, X; Huang, S; Sun, J, 2016)
"The aim of this study was to investigate the relationship between fever within 2 weeks after the start of sorafenib therapy and treatment efficacy in patients with advanced hepatocellular carcinoma (HCC)."3.83Fever within 2 Weeks of Sorafenib Therapy Predicts Favorable Treatment Efficacy in Patients with Advanced Hepatocellular Carcinoma. ( Goto, H; Hayashi, K; Hirooka, Y; Honda, T; Ishigami, M; Ishikawa, T; Ishizu, Y; Kuzuya, T; Nakano, I, 2016)
"To evaluate the safety and efficacy of combined therapy with transarterial chemoembolization (TACE) and sorafenib for hepatocellular carcinoma (HCC) with portal venous tumour thrombus (PVTT)."3.80Safety and efficacy of transarterial chemoembolization plus sorafenib for hepatocellular carcinoma with portal venous tumour thrombus. ( Li, W; Li, XS; Pan, T; Wang, JP; Wu, PH; Xie, QK; Zhao, M, 2014)
"Sorafenib is a multi-kinase inhibitor currently approved in Japan for unresectable and/or metastatic renal cell carcinoma and unresectable hepatocellular carcinoma."3.79Drug-induced lung injury associated with sorafenib: analysis of all-patient post-marketing surveillance in Japan. ( Fujimoto, K; Gemma, A; Horiuchi-Yamamoto, Y; Inoue, Y; Johkoh, T; Kudoh, S; Sakai, F; Taniguchi, H, 2013)

Research

Studies (8)

TimeframeStudies, this research(%)All Research%
pre-19903 (37.50)18.7374
1990's0 (0.00)18.2507
2000's1 (12.50)29.6817
2010's4 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Pan, T1
Li, XS1
Xie, QK1
Wang, JP1
Li, W1
Wu, PH1
Zhao, M1
Cui, T1
Diao, X1
Chen, X1
Huang, S1
Sun, J1
Kuzuya, T1
Ishigami, M1
Ishizu, Y1
Honda, T1
Hayashi, K1
Ishikawa, T1
Nakano, I1
Goto, H1
Hirooka, Y1
Horiuchi-Yamamoto, Y1
Gemma, A1
Taniguchi, H1
Inoue, Y1
Sakai, F1
Johkoh, T1
Fujimoto, K1
Kudoh, S1
Lee, EJ1
Wu, TS1
Chang, GL1
Li, CY1
Chen, TY1
Lee, MY1
Chen, HY1
Maynard, KI1
Iakimova, K1
Micheva, M1
Bantutova, I1
Ovcharov, R1
Lwoff, A1
Coper, H1
Lison, H1
Rommelspacher, H1
Schulze, G1
Strauss, S1

Other Studies

8 other studies available for niacinamide and Fever

ArticleYear
Safety and efficacy of transarterial chemoembolization plus sorafenib for hepatocellular carcinoma with portal venous tumour thrombus.
    Clinical radiology, 2014, Volume: 69, Issue:12

    Topics: Adult; Aged; Antineoplastic Agents; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Combi

2014
A case report: delayed high fever and maculopapules during Sorafenib treatment of ectopic hepatocellular carcinoma.
    BMC cancer, 2016, 07-27, Volume: 16

    Topics: Carcinoma, Hepatocellular; Drug Eruptions; Fever; Humans; Liver Neoplasms; Male; Middle Aged; Niacin

2016
Fever within 2 Weeks of Sorafenib Therapy Predicts Favorable Treatment Efficacy in Patients with Advanced Hepatocellular Carcinoma.
    Oncology, 2016, Volume: 91, Issue:5

    Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Carcinoma, Hepatocellular; Contrast Media; Fe

2016
Drug-induced lung injury associated with sorafenib: analysis of all-patient post-marketing surveillance in Japan.
    International journal of clinical oncology, 2013, Volume: 18, Issue:4

    Topics: Aged; Aged, 80 and over; Antineoplastic Agents; Carcinoma, Hepatocellular; Carcinoma, Renal Cell; Co

2013
Delayed treatment with nicotinamide inhibits brain energy depletion, improves cerebral microperfusion, reduces brain infarct volume, but does not alter neurobehavioral outcome following permanent focal cerebral ischemia in Sprague Dawley rats.
    Current neurovascular research, 2006, Volume: 3, Issue:3

    Topics: Adenine; Adenosine Triphosphate; Animals; Behavior, Animal; Brain; Brain Chemistry; Cerebrovascular

2006
[Inhibition of morphine hyperthermia, induced by nicotinamide].
    Eksperimentalna meditsina i morfologiia, 1989, Volume: 28, Issue:1

    Topics: Animals; Fever; Male; Morphine; Niacinamide; Rats; Rats, Inbred Strains

1989
From protozoa to bacteria and viruses. Fifty years with microbes (André Lwoff).
    Annual review of microbiology, 1971, Volume: 25

    Topics: Bibliographies as Topic; Ciliophora; Crustacea; Eukaryota; Eye; Fever; France; Growth Substances; He

1971
The influence of adrenergic receptor-blocking agents, amphetamine, and 6-aminonicotinamide on thermoregulation.
    Naunyn-Schmiedebergs Archiv fur Pharmakologie, 1971, Volume: 270, Issue:4

    Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Amines; Amphetamine; Animals; Body Temper

1971